MENU
Lineage Cell Therapeutics (LCTX) Ownership - Who owns Lineage Cell Therapeutics?
Profile
Industry
N/A
Address
2173 Salk Avenue
Phone
+1 442 287-8990
Employees
75
Web
https://www.lineagecell.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
164.48M
P/E Ratio
N/A
Total Cash
38.5M
Projected Growth
N/A
Total Debt
2.95M
Revenue
6.19M
Risk (Beta)
1.47
Dividend Yield
N/A
Total Cash/Share
0.20
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
LCTX
Capitalization
164M
P/E Ratio
N/A
Risk (Beta)
1.47
Dividend Yield
N/A
Total Cash
38.5M
Total Cash/Share
0.20
Total Debt
2.95M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
6.19M
ROE
N/A
Book Value
68.3M
P/B Ratio
2.41
Cash Flow
N/A
Earnings
-0.13
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
468M
Current Ratio
2.64
Current Revenue Per Employee
18773.33
Dividends Per Share - Security
N/A
EBITDA
-24.93M
Float
N/A
Float - Current
N/A
Gross Income Margin
96.88
Revenue To Assets
-22.55
Shares Held By Institutions
122M
Shares Outstanding - Current
189M
Total Liabilities
35.9M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-20.092
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, and neurological conditions
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2173 Salk Avenue
Phone
+1 442 287-8990
Employees
75
Web
https://www.lineagecell.com